1/30
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Father of Epidemiology
John Snow
1854 cholera outbreak in London
focus of epidemiology
Monitoring public health, responding to disease outbreaks, and investigating emerging diseases
monitoring public health
morbidity and mortality rates
respond to disease outbreaks, epidemics, and pandemics
determine causes of outbreaks
institute control measures
investigating emerging and reemerging diseases
determine risk factors
recommend control measures
sporadic disease
occasionally, irregular intervals
endemic disease
steady low-level frequency
common cold
hyperendemic diseases
gradually increase
common cold in the winter
outbreak
sudden, unexpected occurrence of disease
epidemic
sudden increase in frequency
index case
pandemic
usually worldwide
H1N1
diseases in the US
Public health surveillance
changed leading cause of death in the US
Longer life expectancy → more sedentary lifestyle → metabolic diseases
pattern of infectious disease in a population
caused by microorganisms
communicable disease
can be transmitted
not all infectious diseases are communicable
types of epidemics
common-source epidemic
propagated epidemic
herd immunity
Level can be altered by changes in pathogen
antigenic shift – small change
antigenic drift – large change
if more of population is immune, there is less disease transmission
what 3 factors contribute to reemerging and emerging diseases
animal
agricultural intensification
human
encroachment
altered ecologies
introduction of exotic species
urbanization
population increase
global travel
biomedical manipulation
environment
climate change
nosocomial infections
aka hospital-acquired infections (HAI)
5 to 10% of all hospital patients
Normal microbiota & antibiotic-resistance
ESKAPE
what is ESKAPE
Enterococcus faecium
Staphylococcus aureus
Klebsiella pneumoniae
Acinetobacter baumannii
Pseudomonas aeruginosa
Enterobacter spp.
vaccine
whole-pathogen vaccines
acellular or subunit vaccines
recombinant/DNA/RNA vaccines
what leads to immunization
adjuvants
adjuvants
nontoxic material in vax
oil in water emulsions, aluminum hydroxide salts, beeswax
immunized hosts: who and when?
Vaccination of children should begin at ~2 months
Further vaccination depends on risk
living in close communities
reduced immunity
international travelers
health-care workers
most current vaccines active against bacteria and viruses are
whole cell vaccines
live, attenuated vaccines
inactivated vax
attenuated vaccines
a single dose
Less stable
stimulate humoral and cell-mediated immunity
immunosuppressed at risk attenuated may revert to virulent
Sabin - 1960
inactivated vaccines
are less immunogenic/pathogenic, require boosters
More stable
not good at stimulating cell-mediated immunity or secretory IgA
Salk - 1955
acellular or subunit vaccines
Use of purified molecules from microbes
Forms of subunit vaccines
capsular polysaccharides
recombinant surface antigens
inactivated exotoxins (toxoids)
DNA vaccines
DNA directly introduced into host cell
DNA taken into nucleus and pathogen’s DNA fragment is expressed
host immune system responds
Johnson & Johnson and AstraZeneca COVID-19 vaccine
adenovirus
mRNA vaccines
Hurdles to overcome:
mature mRNA
detrimental innate immunogenicity
delivery of mRNA
Can be used for
bacterial, eukaryotic or viral diseases
cancer
bioterrorism
“Intentional or threatened use of viruses, bacteria, fungi, or toxins from living organisms to produce death or disease in humans, animals, and plants”
Infect wells with ergots
Dip arrows in decomposing bodies
Infected bodies thrown over city walls
Use of bacterial spores
diseases considered bioterrorism
Anthrax
Botulism
Smallpox
Plague
Cholera
Hemorrhagic fever